Krsnaa Diagnostics Limited (IN:KRSNAA)
:KRSNAA
Want to see IN:KRSNAA full AI Analyst Report?
KRSNAA Stock Chart & Stats
₹735.10
₹3.75(0.41%)
At close: 4:00 PM EST
₹735.10
₹3.75(0.41%)
Day’s Range― - ―
52-Week Range₹502.20 - ₹891.80
Previous CloseN/A
Volume110.72K
Average Volume (3M)12.28K
Market Cap
₹17.25B
Enterprise Value₹19.56B
Total Cash (Recent Filing)₹1.60B
Total Debt (Recent Filing)₹2.86B
Price to Earnings (P/E)17.1
Beta1.06
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.38%
Share Statistics
EPS (TTM)26.14
Shares Outstanding32,438,670
10 Day Avg. Volume19,408
30 Day Avg. Volume12,281
Financial Highlights & Ratios
PEG Ratio0.55
Price to Book (P/B)1.72
Price to Sales (P/S)2.18
P/FCF Ratio-17.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)48.1
Revenue Forecast (FY)₹9.66B
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthSustained top-line growth from ~4.55B to ~7.73B over 2022–2026 indicates persistent demand for diagnostic services. This revenue momentum supports scale benefits, capacity utilisation and provides a foundation for steady long-term earnings and reinvestment.
Improved Balance-sheet And DeleveragingMeaningful debt reduction and moderate leverage (debt-to-equity ~0.04–0.23 recently) materially improve financial flexibility. A stronger balance sheet lowers refinancing risk, supports capital spending for network expansion and cushions against sector cyclicality.
PPP/outsourcing Business ModelA core PPP/outsourcing model secures contracted volumes and institutional relationships, creating a differentiated route to stable utilization. Long-term government and hospital partnerships drive recurring revenue, predictable site economics and scalable rollouts.
Bears Say
Persistent Negative Free Cash FlowChronic negative free cash flow despite positive operating cash flow suggests heavy capex, working-capital strain or receivable build-up. This reduces internal funding for expansion, increases reliance on external financing and constrains shareholder returns over the medium term.
Volatile Profitability And MarginsMaterial margin swings across years show cost structure and pricing vulnerability. Such volatility undermines predictability of earnings, complicates long-term planning, and raises execution risk for sustaining improved profitability through cycles.
Exposure To Government Receivables And Payment TimingReliance on government contracts and timely payments creates structural cash-flow risk; delayed receivables can amplify working-capital needs, force short-term funding, and impair ability to fund capex or absorb local operational disruptions.
Krsnaa Diagnostics Limited News
KRSNAA FAQ
What was Krsnaa Diagnostics Limited’s price range in the past 12 months?
Krsnaa Diagnostics Limited lowest stock price was ₹502.20 and its highest was ₹891.80 in the past 12 months.
What is Krsnaa Diagnostics Limited’s market cap?
Krsnaa Diagnostics Limited’s market cap is ₹17.25B.
When is Krsnaa Diagnostics Limited’s upcoming earnings report date?
Krsnaa Diagnostics Limited’s upcoming earnings report date is Aug 06, 2026 which is in 54 days.
How were Krsnaa Diagnostics Limited’s earnings last quarter?
Krsnaa Diagnostics Limited released its earnings results on May 25, 2026. The company reported ₹9.655 earnings per share for the quarter, beating the consensus estimate of ₹2.45 by ₹7.205.
Is Krsnaa Diagnostics Limited overvalued?
According to Wall Street analysts Krsnaa Diagnostics Limited’s price is currently Overvalued.
Does Krsnaa Diagnostics Limited pay dividends?
Krsnaa Diagnostics Limited pays a Annually dividend of ₹2.75 which represents an annual dividend yield of 0.38%. See more information on Krsnaa Diagnostics Limited dividends here
What is Krsnaa Diagnostics Limited’s EPS estimate?
Krsnaa Diagnostics Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Krsnaa Diagnostics Limited have?
Krsnaa Diagnostics Limited has 32,438,670 shares outstanding.
What happened to Krsnaa Diagnostics Limited’s price movement after its last earnings report?
Krsnaa Diagnostics Limited reported an EPS of ₹9.655 in its last earnings report, beating expectations of ₹2.45. Following the earnings report the stock price went down -1.219%.
Which hedge fund is a major shareholder of Krsnaa Diagnostics Limited?
Currently, no hedge funds are holding shares in IN:KRSNAA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited specializes in delivering a comprehensive range of diagnostic solutions. The company utilizes technology to provide services such as radiology, clinical pathology, and tele-radiology to diverse clients, including public and private healthcare facilities, medical colleges, and local community health centers. By December 31, 2020, its extensive network featured 1,801 diagnostic centers distributed across 13 Indian states. Established in 2010, the company maintains its headquarters in Pune, India.
Technical Analysis
Dr. Lal PathLabs Limited
―
Metropolis Healthcare Ltd.
―
Suraksha Diagnostic Ltd.
―
Thyrocare Technologies Ltd
―
Vijaya Diagnostic Centre Ltd.
―